Searched for
BIOPHARMA INDUSTRY
Piyush Goyal meets Ernst & Young CEO, discusses India's role in global supply chainsUnion Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...10 Jun, 2026, 07.08 AM IST- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...03 Jun, 2026, 02.36 PM IST
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...22 May, 2026, 04.40 PM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- Biocon's Shaw says Budget boosts India’s health and innovation agendaThe Union Budget is making a significant investment in India's health and innovation. Biopharma has been identified as a key strategic sect...02 Feb, 2026, 02.43 PM IST
- Budget 2026 bets on biopharma, SME capital to drive resilient growth: Industry leadersThe Union Budget 2026-27 focuses on fortifying the Indian economy against global volatility through strategic investments in technology, he...02 Feb, 2026, 12.56 PM IST
- Biocon Biologics sees Biopharma SHAKTI as major boost for India’s biosimilar ambitionsIndia's biopharmaceutical sector receives a significant boost with the Union Budget's ₹10,000 crore Biopharma SHAKTI programme. This initia...01 Feb, 2026, 03.21 PM IST
- Budget 2026: Sitharaman launches 'Biopharma Shakti' with a Rs 10,000-crore bet to heal India, power manufacturingUnion Budget 2026: With the announcement of the 'Biopharma Shakti' initiative, India is gearing up to take the world stage in biopharmaceut...01 Feb, 2026, 01.39 PM IST
- Budget 2026: Sitharaman’s six-point plan to propel India’s next growth phaseUnion Budget 2026: Finance Minister Nirmala Sitharaman has presented a six-point plan to boost India's economy. The strategy prioritizes ma...01 Feb, 2026, 11.40 AM IST
- India emerging as favourable destination to conduct global clinical trials: ReportThe joint report by the USA India Chamber of Commerce & PwC India titled, “Clinical Trial opportunities in India” which will be released at...03 May, 2023, 11.03 AM IST
- Syngene's CEO Jonathan Hunt says India now offers intellectual arbitrage to firms“A young scientist joining a company like Syngene can travel the world scientifically without ever having to leave Bengaluru. It provides o...31 Jul, 2021, 11.37 AM IST
- Top government officials, leaders from industry, academicians to take part in India-US Biopharma and Healthcare SummitNITI Aayog CEO Amitabh Kant, Pfizer CEO Dr Alberta Bourla, National Institutes of Health (NIH) Director Dr Francis Collins and Food and Dru...19 Jun, 2021, 10.15 AM IST
- Pharma sector needs global collaboration: Industry leaders, government officialsAhead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...31 Aug, 2020, 08.49 AM IST
- Telangana plans country’s first biopharma hubTelangana government proposes to set up India’s first Biopharma-Hub to provide support to the biopharma research and development activities.01 Aug, 2018, 10.50 AM IST
- India's health and biopharma sector deserve more attentionIndia's health and innovative and biopharma sector deserves better attention from the government to help realise its full potential12 Jun, 2015, 08.36 AM IST
- Job of the Week: BiostatisticianBiostatistics is the science of obtaining, analysing and interpreting data using statistical theory and methods to address problems in biol...10 Dec, 2013, 05.17 AM IST
- Intas Biopharma in talks with Japanese co for outlicensingIntas Biopharmaceutical Ltd, a group company of the Rs 1,600-crore Intas Pharmaceuticals Ltd, would soon enter into an out-licensing and su...27 Sep, 2010, 12.24 PM IST
Load More
